Related Experiment Video
Updated: Jul 9, 2026
06:09
Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
Published on: August 20, 2019
Mechanisms of ET-1-induced endothelial dysfunction
1Actelion Pharmaceuticals Ltd., CH-4123 Allschwil, Switzerland. marc.iglarz@actelion.com
Journal of Cardiovascular Pharmacology
|December 20, 2007
Summary
Endothelial dysfunction is an early sign of cardiovascular disease. Endothelin receptor antagonists show promise in correcting this dysfunction and improving cardiovascular health.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Endothelial dysfunction is an early indicator in cardiovascular disease pathophysiology.
- It predicts cardiovascular events in conditions like coronary artery disease, peripheral artery disease, and hypertension.
- Restoring endothelial function is a critical therapeutic target.
Purpose of the Study:
- To elucidate mechanisms of endothelin-1 (ET-1) induced endothelial dysfunction.
- To review pathological conditions linked to ET-1 related endothelial dysfunction.
- To synthesize evidence on endothelin receptor antagonists (ERAs) for endothelial function improvement.
Main Methods:
- Review of preclinical and clinical data.
- Analysis of proposed mechanisms of ET-1 action.
- Evidence synthesis on ERA efficacy.
Main Results:
- ET-1 contributes to endothelial dysfunction through various proposed mechanisms.
- Endothelial dysfunction is implicated in diverse cardiovascular pathologies.
- ERAs demonstrate potential in improving endothelial function.
Conclusions:
- Endothelin receptor antagonists represent a promising therapeutic class for endothelial dysfunction.
- Targeting ET-1 pathways may offer a novel approach to cardiovascular disease management.
- Further research into ERAs is warranted for various endothelial dysfunction-related diseases.
Related Concept Videos
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...